IART
Integra Lifesciences Holdings Corp

369
Mkt Cap
$923.12M
Volume
1M
52W High
$27.13
52W Low
$10.87
PE Ratio
-1.73
IART Fundamentals
Price
$11.05
Prev Close
$11.15
Open
$11.34
50D MA
$13.80
Beta
1.22
Avg. Volume
1.14M
EPS (Annual)
-$0.0902
P/B
0.84
Rev/Employee
$366,361.92
Loading...
Loading...
News
all
press releases
Campbell & CO Investment Adviser LLC Acquires Shares of 51,490 Integra LifeSciences Holdings Corporation $IART
Campbell & CO Investment Adviser LLC bought a new position in shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART - Free Report) in the second quarter, according to its most recent Form...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Integra LifeSciences (NASDAQ:IART) Shares Up 8.3% After Insider Buying Activity
Integra LifeSciences (NASDAQ:IART) Stock Price Up 8.3% Following Insider Buying Activity...
MarketBeat·12d ago
News Placeholder
Integra LifeSciences (NASDAQ:IART) Rating Increased to Buy at Wall Street Zen
Wall Street Zen raised shares of Integra LifeSciences from a "hold" rating to a "buy" rating in a report on Saturday...
MarketBeat·13d ago
News Placeholder
Jeffrey Graves Purchases 9,000 Shares of Integra LifeSciences (NASDAQ:IART) Stock
Integra LifeSciences Holdings Corporation (NASDAQ:IART - Get Free Report) Director Jeffrey Graves purchased 9,000 shares of Integra LifeSciences stock in a transaction that occurred on Wednesday...
MarketBeat·13d ago
News Placeholder
Integra LifeSciences (NASDAQ:IART) Director Jeffrey Graves Purchases 9,000 Shares
Integra LifeSciences Holdings Corporation (NASDAQ:IART - Get Free Report) Director Jeffrey Graves bought 9,000 shares of the stock in a transaction dated Wednesday, November 5th. The stock was...
MarketBeat·13d ago
News Placeholder
Integra (IART) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·21d ago
News Placeholder
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·21d ago
News Placeholder
Should You Continue to Hold Integra Stock in Your Portfolio Now?
IART shows strong demand in neurosurgery and Tissue Technologies but faces macro and liquidity challenges.
Zacks·2mo ago
News Placeholder
Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks·4mo ago
News Placeholder
Integra LifeSciences (IART) Beats Q2 Earnings and Revenue Estimates
Integra (IART) delivered earnings and revenue surprises of +4.65% and +5.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago

Latest IART News

View

Advertisement|Remove ads.

Advertisement|Remove ads.